MYRON Z. HOLUBIAK - 07 Nov 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Vice Chairman, Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
4
Filing time
12 Nov 2024, 17:00:18 UTC
Previous filing
27 Sep 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 1,992,243 07 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +350,000 $0.000000 350,000 07 Nov 2024 Common Stock 350,000 $0.3800 Direct F1
transaction CTXR Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 07 Nov 2024 Common Stock 75,000 $0.3800 See footnote F2
holding CTXR Warrant to Purchase Common Stock 784,314 07 Nov 2024 Common Stock 784,314 $1.15 Direct F3
holding CTXR Warrant to Purchase Common Stock 558,597 07 Nov 2024 Common Stock 558,597 $0.7700 Direct F3
holding CTXR Warrant to Purchase Common Stock 129,450 07 Nov 2024 Common Stock 129,450 $1.42 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 400,000 07 Nov 2024 Common Stock 400,000 $0.7000 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 400,000 07 Nov 2024 Common Stock 400,000 $1.25 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 650,000 07 Nov 2024 Common Stock 650,000 $2.04 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 15,000 07 Nov 2024 Common Stock 15,000 $2.04 See footnote F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 07 Nov 2024 Common Stock 300,000 $2.00 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 10,000 07 Nov 2024 Common Stock 10,000 $2.00 See footnote F2
holding CTXR Stock Option (Right to Purchase Common Stock) 200,000 07 Nov 2024 Common Stock 200,000 $1.01 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 175,000 07 Nov 2024 Common Stock 175,000 $0.6700 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 150,000 07 Nov 2024 Common Stock 150,000 $1.62 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 40,000 07 Nov 2024 Common Stock 40,000 $3.45 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 26,667 07 Nov 2024 Common Stock 26,667 $8.10 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2 The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
F3 The warrant is fully vested and exercisable immediately.
F4 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F5 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F6 The options are vested in full and exercisable immediately.